ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Densy
|
85 |
20K |
2 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
85
|
20K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Densy
|
85 |
20K |
14 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
85
|
20K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Densy
|
85 |
20K |
25 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
85
|
20K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Densy
|
85 |
20K |
31 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
85
|
20K
|
31
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Densy
|
147 |
35K |
12 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
147
|
35K
|
12
|
|
Charts
|
PAA Biotech |
Re:
GENERAL MEETING VOTING CORRECTLY
|
|
Densy
|
33 |
7.8K |
3 |
01/06/23 |
01/06/23 |
Charts
|
33
|
7.8K
|
3
|
|
Charts
|
PAA Biotech |
Re:
GENERAL MEETING VOTING CORRECTLY
|
|
Densy
|
33 |
7.8K |
8 |
01/06/23 |
01/06/23 |
Charts
|
33
|
7.8K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
4 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
121
|
27K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
6 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
121
|
27K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
7 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
121
|
27K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
2 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
6 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
5 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
7 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
9 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
6 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
88
|
17K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Densy
|
88 |
17K |
10 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
88
|
17K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Densy
|
205 |
45K |
6 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
205
|
45K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
Densy
|
46 |
10K |
6 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
46
|
10K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
Densy
|
46 |
10K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
46
|
10K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Densy
|
147 |
35K |
4 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
35K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Densy
|
147 |
35K |
9 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
35K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Densy
|
147 |
35K |
19 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
35K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Densy
|
147 |
35K |
11 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
35K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
Densy
|
65 |
17K |
8 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
65
|
17K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Densy
|
205 |
45K |
7 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
205
|
45K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
Densy
|
65 |
17K |
14 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
65
|
17K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
Densy
|
65 |
17K |
13 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
65
|
17K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $2.5m via Placement
|
|
Densy
|
138 |
30K |
5 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
138
|
30K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Densy
|
11 |
2.6K |
10 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
11
|
2.6K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification regarding unquoted securities - PAA
|
|
Densy
|
7 |
1.9K |
9 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
7
|
1.9K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification regarding unquoted securities - PAA
|
|
Densy
|
7 |
1.9K |
10 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
7
|
1.9K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
3 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
121
|
27K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
14 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
121
|
27K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
19 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
121
|
27K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
25 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
121
|
27K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
8 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
84
|
23K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
12 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
84
|
23K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Densy
|
121 |
27K |
11 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
121
|
27K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
2 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
84
|
23K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
6 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
84
|
23K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
18 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
84
|
23K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Densy
|
84 |
23K |
34 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
84
|
23K
|
34
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $2.5m via Placement
|
|
Densy
|
138 |
30K |
22 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
138
|
30K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $2.5m via Placement
|
|
Densy
|
138 |
30K |
19 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
138
|
30K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $2.5m via Placement
|
|
Densy
|
138 |
30K |
14 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
138
|
30K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust launches international CEO search
|
|
Densy
|
95 |
24K |
6 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
95
|
24K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust launches international CEO search
|
|
Densy
|
95 |
24K |
11 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
95
|
24K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Bella's Monepantel Trial
|
|
Densy
|
127 |
29K |
10 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
127
|
29K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Completes Enrolment of Cohort 2
|
|
Densy
|
104 |
28K |
20 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
104
|
28K
|
20
|
|